Sulpiride (or DOLMATIL®) is mainly prescribed to treat schizophrenia and major depressive disorder.
Class: Atypical (AAP)
FDA Approval: International Only (Asia, Europe, Central America, South America, Africa)
Dosage Forms: 200 mg, 400 mg, 600 mg, 800 mg, 1,200 mg
Biological Half-life: 6-8 hours
Side Effects: Dizziness, blurred vision, rashes, constipation, libido changes, weight gain
Routes of Administration: Oral, IM
Pregnancy Category: N/A